{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:39:40Z","timestamp":1792409980743,"version":"4.4.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous research has supported the association between the triglyceride\u2013glucose index (TyG index) and the incidence and prognosis of cardiovascular disease. However, the association between the TyG index and the prognosis of patients with acute coronary syndrome (ACS) without diabetes mellitus (DM) who underwent emergency percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) has not been thoroughly investigated, and these patients may easily be neglected. Therefore, this study aimed to investigate the association between the TyG index and major adverse cardiovascular and cerebrovascular events (MACCEs) in Chinese ACS patients without DM who underwent emergency PCI with DES.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The total number of ACS patients without DM who underwent emergency PCI with DES for this study was 1650. Ln [fasting triglycerides (mg\/dL) \u00d7fasting plasma glucose (mg\/dL)\/2] is the formula used to calculate the TyG index. According to the TyG index, we classified the patients into two groups. The frequency of the following endpoint events was calculated and compared between the two groups: all-cause death, non-fatal myocardial infarction (MI), non-fatal ischemia stroke, ischemia-driven revascularization and cardiac rehospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After a median of 47 months of follow-up [47 (40, 54)], 437 (26.5%) endpoint events were recorded in total. The TyG index was further demonstrated to be independent of MACCE by multivariable Cox regression analysis (hazard ratio [HR], 1.493; 95% confidence interval [CI], 1.230\u20131.812; <jats:italic>p&amp;lt;<\/jats:italic>0.001). The TyG index\u22657.08 group had a considerably greater incidence of MACCE (30.3% vs. 22.7% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>&amp;lt;0.001), cardiac death (4.0% vs. 2.3% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>=0.047), and ischemia-driven revascularization (5.7% vs. 3.6% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>=0.046) than the TyG index&amp;lt;7.08 group. Between the two groups, there was no discernible difference in all-cause death (5.6% vs. 3.8% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>=0.080), non-fatal MI (1.0% vs. 0.2% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>=0.057), non-fatal ischemic stroke (1.6% vs. 1.0% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>=0.272), and cardiac rehospitalization (16.5% vs. 14.1% in the TyG index&amp;lt;7.08 group, <jats:italic>p<\/jats:italic>=0.171).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For ACS patients without DM who received emergency PCI with DES, the TyG index might be an independent predictor of MACCE.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1101952","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T07:58:48Z","timestamp":1676447928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["High triglyceride\u2013glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents"],"prefix":"10.3389","volume":"14","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-bai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-fei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.2049","article-title":"Updates on acute coronary syndrome: A review","volume":"1","author":"Eisen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/cir.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: A report from the American heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide realworld data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq326","article-title":"Underestimated and under-recognized: The late consequences of acute coronary syndrome (GRACE UK-Belgian study)","volume":"31","author":"Fox","year":"2010","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4b","DOI":"10.1016\/j.amjcard.2012.08.029","article-title":"Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: Treating \"sick fat\" through improving fat function with antidiabetes therapies","volume":"110","author":"Bays","year":"2012","journal-title":"Am J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e001412","DOI":"10.1161\/jaha.114.001412","article-title":"Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg\/dL","volume":"4","author":"Li","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00141","article-title":"Insulin resistance and atherosclerosis: Implications for insulin-sensitizing agents","volume":"40","author":"Di Pino","year":"2019","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0146-3","article-title":"Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance","volume":"13","author":"Du","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ypmed.2016.01.022","article-title":"Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The vascular-metabolic CUN cohort","volume":"86","author":"Navarro-Gonz\u00e1lez","year":"2016","journal-title":"Prev Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12933-021-01238-1","article-title":"Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: An 11-year follow-up","volume":"20","author":"Wang","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-020-01210-5","article-title":"Triglyceride-glucose index is associated with the risk of myocardial infarction: An 11-year prospective study in the kailuan cohort","volume":"20","author":"Tian","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.774781","article-title":"Prognostic significance of triglyceride-glucose index for adverse cardiovascular events in patients with coronary artery disease: A systematic review and meta-analysis","volume":"8","author":"Luo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.11.039","article-title":"Relation of fasting insulin plasma levels to restenosis after elective coronary stent implantation in patients without diabetes mellitus","volume":"93","author":"Radke","year":"2004","journal-title":"Am J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/01.Cir.0000095272.67948.17","article-title":"Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting","volume":"108","author":"Piatti","year":"2003","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2012.08.022","article-title":"Impact of insulin resistance on 1-year clinical outcomes in non-diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents","volume":"61","author":"Hwang","year":"2013","journal-title":"J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","year":"2011","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(19)30158-5","article-title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: A prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"7","author":"Ray","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-Art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e52036","DOI":"10.1371\/journal.pone.0052036","article-title":"Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis","volume":"7","author":"Gast","year":"2012","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.781","article-title":"Insulin sensitivity, insulinemia, and coronary artery disease: The insulin resistance atherosclerosis study","volume":"27","author":"Rewers","year":"2004","journal-title":"Diabetes Care"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi310","article-title":"Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients","volume":"26","author":"Tenenbaum","year":"2005","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/0003319718809931","article-title":"Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: Insights from optical coherence tomography","volume":"70","author":"Wu","year":"2019","journal-title":"Angiology."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0919","article-title":"Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: The bruneck study","volume":"30","author":"Bonora","year":"2007","journal-title":"Diabetes Care"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.12.023","article-title":"Impact of TCFA on unanticipated ischemic events in medically treated diabetes mellitus: Insights from the PROSPECT study","volume":"10","author":"Kedhi","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12583","article-title":"The TyG index may predict the development of cardiovascular events","volume":"46","author":"S\u00e1nchez-\u00cd\u00f1igo","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2017.05.142","article-title":"The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women","volume":"27","author":"Lambrinoudaki","year":"2018","journal-title":"Heart Lung Circ"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2019.09.015","article-title":"Value of triglyceride-glucose index for the estimation of ischemic stroke risk: Insights from a general population","volume":"30","author":"Shi","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1133-6","article-title":"The global burden of diabetic kidney disease: Time trends and gender gaps","volume":"19","author":"Thomas","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-016-0368-7","article-title":"Metabolic markers associated with insulin resistance predict type 2 diabetes in koreans with normal blood pressure or prehypertension","volume":"15","author":"Sung","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymgme.2014.11.003","article-title":"Mathematical modeling of the insulin signal transduction pathway for prediction of insulin sensitivity from expression data","volume":"114","author":"Ho","year":"2015","journal-title":"Mol Genet Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.07.003","article-title":"The burden of diabetes mellitus in patients with coronary heart disease: A methodological approach to assess quality-adjusted life-years based on individual-level longitudinal survey data","volume":"18","author":"Laxy","year":"2015","journal-title":"Value Health"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac073","article-title":"Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease","volume":"15","author":"Quiroga","year":"2022","journal-title":"Clin Kidney J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2022.08.006","article-title":"The predictive value of triglyceride-glucose index for in-hospital and one-year mortality in elderly non-diabetic patients with ST-segment elevation myocardial infarction","volume":"19","author":"\u015eayl\u0131k","year":"2022","journal-title":"J Geriatr Cardiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1101952\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T07:59:07Z","timestamp":1676447947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1101952\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":45,"alternative-id":["10.3389\/fendo.2023.1101952"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1101952","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"article-number":"1101952"}}